The global point of care molecular diagnostics market is growing at a significant rate due to the intensifying occurrence of infectious diseases, and increasing focus on decentralized diagnostics. Different types of products and services contributed to the point of care molecular diagnostics market size.

The increasing demand for CLIA-waived molecular POC tests, increasing public awareness levels pertaining to pre-disease detection and increasing focus on decentralized diagnostics are the primary growth drivers for point of care molecular diagnostics market. It has become feasible to detect numerous viral and bacterial organisms precisely from a patient specimen with the launch of amplification methods for other nucleic acid and polymerase chain reaction.

Request for Sample Copy of this Research Report at: https://www.vynzresearch.com/healthcare/point-of-care-molecular-diagnostics-market/request-sample

Intensifying occurrence of infectious diseases such as HIV, tuberculosis, influenza, and others is boosting the growth of the point of care molecular diagnostics market.

Mounting penetration of POC molecular diagnostic tests in China, Brazil and India, shifting trend from hospital testing to point of care testing, and increasing R&D activities in molecular diagnostic testing are also fueling the growth of the point of care molecular diagnostics market.

Geographically, North America is the largest point of care molecular diagnostics market due to intensifying occurrence of infectious diseases, increasing demand for fast and portable tests, increasing government initiatives, increasing focus on preventive care to reduce the economic burden and increasing number of CLIA product approvals.

Browse Full Research Report Description at: https://www.vynzresearch.com/healthcare/point-of-care-molecular-diagnostics-market

Asia-Pacific is observed to witness the fastest growth in the market as the region comprises of the largest population. In addition, increasing demand for influenza A/B tests and growth initiatives by market players are also creating a positive impact on the point of care molecular diagnostics industry growth in the region.

Abbott Laboratories, Danaher Corporation, Biomérieux Sa, Roche Diagnostics, Quidel, Meridian Bioscience, Mesa Biotech, Genepoc, DxNA, Atlas Genetics are some of the key players offering the point of care molecular diagnostics products.

Source: VynZ Research